Cisapride is a prokinetic drug that previously was licensed for gastro-oesophageal reflux, reduced gastric motility associated with a range of conditions, and non-ulcer dyspepsia.
This drug was withdrawn from marketing in the UK from 28th July 2000 until further notice . This is because cisapride can prolong the QT interval, which may lead to rare but life-threatening ventricular arrythmias. The committee on Safety of Medicines has advised that all treatment with cisapride should be stopped and patients should be changed to an alternative treatment as necessary.
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.